drugset / Trial / NCT06534944

NAD Supplementation and Vascular Health in PAD

NCT06534944

Phase 1/2 Completed 8 enrolled University of Oklahoma
NaSingle-groupOpen-labelBasic science

Summary

This pilot open-label clinical trial was designed to investigate whether 4-week supplementation with 1g daily NR impacts endothelial function in peripheral circulation, cerebrovascular hemodynamics, cognitive function in older adults with peripheral artery disease.

Timeline

Start
2023-02-27
Primary completion
2024-07-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotinamide riboside Small molecule 1 g Oral